Real-time Stock quotes, portfolio, LIVE TV and more.
|
Jun 06, 2012, 03.40 PM IST
SPA Research is bullish on Phillips Carbon Black and has recommended buy rating on the stock with a target of Rs 170 in its June 5, 2012 research report.
SPA Research is bullish on Phillips Carbon Black and has recommended buy rating on the stock with a target of Rs 170 in its June 5, 2012 research report.
“PCBL reported below than expected set of numbers in Q4FY12. While the top-line was largely in-line with estimates, profit for the quarter was hit by lower than expected EBITDA margins, higher interest outgo & forex loss of INR 134 mn. EBITDA Margin squeezed off by 541 bps YoY & 113 bps QoQ to 8.51%, led by higher input costs & other operating expenses. We introduce FY14 estimates & roll-forward our valuations by 12 months. We retain our "BUY" recommendation & target of INR 170.” “In Q4FY12, PCBL reported net sales of INR 5396 mn, up by 21.7% YoY & 4.9% QoQ. PAT at INR 51 mn was down by 84.8% YoY & 74.3% QoQ led by lower than expected EBITDA margins, higher interest outgo & forex loss of INR 134 mn in Q4FY12 (profit of INR 26 mn in Q4FY11) Revenue from carbon black (CB) segment having ~96% revenue contribution stood at INR 5180 mn, up by 22.4% YoY & 5.3% QoQ. Revenue from power segment contributing ~4% to total revenue stood at INR 305 mn, up by 7.6% YoY & 3.6% QoQ. EBIT margin in CB segment contracted by 670 bps YoY & 268 bps QoQ to 3.44%. EBITDA margins at 8.51% contracted by 541 bps YoY & 113 bps QoQ. This was on the back of higher than expected increase in raw material costs & higher other operating expenses. In FY12, raw material costs stood at 78.1% of net sales vis-à-vis 72.7% in the same period last year.” “We have revised our estimates for FY13E to incorporate lower volumes, due to lower offtake by the tyre companies coupled with higher & cheap imports from China (7000-7500 MT/month vis-àvis usual run-rate of 2500 MT). We expect PCBL's top-line & bottomline to register a CAGR of 8% & 24% over the next 2 years. We introduce FY14 estimates & retain our "BUY" recommendation & target of INR 170 in 18 months at 4XFY14E EV/EBITDA,” says SPA Research report. Bodies Corporate holding more than 50% in Indian cos Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
To read the full report click here Set email alert for |
News Videos
|